Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1977 2
1978 4
1979 5
1980 3
1981 4
1982 2
1983 6
1984 4
1985 4
1986 4
1988 4
1989 3
1990 7
1991 6
1992 2
1993 5
1994 2
1995 6
1996 7
1997 5
1998 6
1999 4
2000 4
2001 3
2002 4
2003 4
2004 3
2005 3
2006 3
2007 8
2008 6
2009 14
2010 15
2011 12
2012 11
2013 13
2014 11
2015 13
2016 9
2017 11
2018 2
2019 2
2020 4
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

237 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data.
Vale CL, Fisher D, Kneebone A, Parker C, Pearse M, Richaud P, Sargos P, Sydes MR, Brawley C, Brihoum M, Brown C, Chabaud S, Cook A, Forcat S, Fraser-Browne C, Latorzeff I, Parmar MKB, Tierney JF; ARTISTIC Meta-analysis Group. Vale CL, et al. Among authors: richaud p. Lancet. 2020 Oct 31;396(10260):1422-1431. doi: 10.1016/S0140-6736(20)31952-8. Epub 2020 Sep 28. Lancet. 2020. PMID: 33002431 Free PMC article.
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial.
Sargos P, Chabaud S, Latorzeff I, Magné N, Benyoucef A, Supiot S, Pasquier D, Abdiche MS, Gilliot O, Graff-Cailleaud P, Silva M, Bergerot P, Baumann P, Belkacemi Y, Azria D, Brihoum M, Soulié M, Richaud P. Sargos P, et al. Among authors: richaud p. Lancet Oncol. 2020 Oct;21(10):1341-1352. doi: 10.1016/S1470-2045(20)30454-X. Lancet Oncol. 2020. PMID: 33002438 Clinical Trial.
Post-Prostatectomy Image-Guided Radiotherapy: The Invisible Target Concept.
Vilotte F, Antoine M, Bobin M, Latorzeff I, Supiot S, Richaud P, Thomas L, Leduc N, Guérif S, Iriondo-Alberdi J, de Crevoisier R, Sargos P. Vilotte F, et al. Among authors: richaud p. Front Oncol. 2017 Mar 9;7:34. doi: 10.3389/fonc.2017.00034. eCollection 2017. Front Oncol. 2017. PMID: 28337425 Free PMC article. Review.
[Management of low-risk prostate cancer].
Rozet F, Bastide C, Beuzeboc P, Cormier L, Fromont G, Hennequin C, Mongiat-Artus P, Peyromaure M, Renard-Penna R, Richaud P, Salomon L, Soulié M; Les membres du comité de cancérologie de l’AFU. Rozet F, et al. Among authors: richaud p. Prog Urol. 2015 Jan;25(1):1-10. doi: 10.1016/j.purol.2014.10.007. Epub 2014 Nov 20. Prog Urol. 2015. PMID: 25454776 Review. French.
[Postoperative radiotherapy of prostate cancer].
Guérif S, Latorzeff I, Lagrange JL, Hennequin C, Supiot S, Garcia A, François P, Soulié M, Richaud P, Salomon L. Guérif S, et al. Among authors: richaud p. Cancer Radiother. 2014 Oct;18(5-6):517-23. doi: 10.1016/j.canrad.2014.07.149. Epub 2014 Sep 5. Cancer Radiother. 2014. PMID: 25195116 Review. French.
The Rationale for Post-Operative Radiation in Localized Bladder Cancer.
Baumann BC, Sargos P, Eapen LJ, Efstathiou JA, Choudhury A, Bahl A, Murthy V, Ballas LK, Fonteyne V, Richaud PM, Zaghloul MS, Christodouleas JP. Baumann BC, et al. Among authors: richaud pm. Bladder Cancer. 2017 Jan 27;3(1):19-30. doi: 10.3233/BLC-160081. Bladder Cancer. 2017. PMID: 28149931 Free PMC article. Review.
Follicular lymphomas--a review of treatment modalities.
Soubeyran P, Debled M, Tchen N, Richaud P, Monnereau A, Bonichon F, Eghbali H. Soubeyran P, et al. Among authors: richaud p. Crit Rev Oncol Hematol. 2000 Jul;35(1):13-32. doi: 10.1016/s1040-8428(00)00066-4. Crit Rev Oncol Hematol. 2000. PMID: 10863149 Review.
Roles of the F-domain in [FeFe] hydrogenase.
Gauquelin C, Baffert C, Richaud P, Kamionka E, Etienne E, Guieysse D, Girbal L, Fourmond V, André I, Guigliarelli B, Léger C, Soucaille P, Meynial-Salles I. Gauquelin C, et al. Among authors: richaud p. Biochim Biophys Acta Bioenerg. 2018 Feb;1859(2):69-77. doi: 10.1016/j.bbabio.2017.08.010. Epub 2017 Aug 24. Biochim Biophys Acta Bioenerg. 2018. PMID: 28842179 Free article.
[Imagery of treated prostate cancer].
Renard-Penna R, Michaud L, Cormier L, Bastide C, Beuzeboc P, Fromont G, Hennequin C, Mongiat-Artus P, Peyromaure M, Rozet F, Richaud P, Salomon L, Soulié M; membres du Comité de cancérologie de l’AFU. Renard-Penna R, et al. Among authors: richaud p. Prog Urol. 2015 Mar;25(3):128-37. doi: 10.1016/j.purol.2014.12.002. Epub 2015 Jan 13. Prog Urol. 2015. PMID: 25595615 Review. French.
Chemotherapy in hormone-sensitive metastatic prostate cancer: Evidences and uncertainties from the literature.
Gravis G, Audenet F, Irani J, Timsit MO, Barthelemy P, Beuzeboc P, Fléchon A, Linassier C, Oudard S, Rebillard X, Richaud P, Rouprêt M, Thiery Vuillemin A, Vincendeau S, Albiges L, Rozet F. Gravis G, et al. Among authors: richaud p. Cancer Treat Rev. 2017 Apr;55:211-217. doi: 10.1016/j.ctrv.2016.09.008. Epub 2016 Sep 10. Cancer Treat Rev. 2017. PMID: 27665366 Free article. Review.
237 results